Warren L. DeSouza
2015
In 2015, Warren L. DeSouza earned a total compensation of $1.7M as Chief Financial Officer at Aimmune Therapeutics.
Compensation breakdown
| Non-Equity Incentive Plan | $76,500 |
|---|---|
| Option Awards | $1,423,504 |
| Salary | $212,500 |
| Total | $1,712,504 |
DeSouza received $1.4M in option awards, accounting for 83% of the total pay in 2015.
DeSouza also received $76.5K in non-equity incentive plan and $212.5K in salary.
Rankings
In 2015, Warren L. DeSouza's compensation ranked 5,359th out of 13,638 executives tracked by ExecPay. In other words, DeSouza earned more than 60.7% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 5,359 out of 13,638 | 61st |
Division Manufacturing | 1,983 out of 5,190 | 62nd |
Major group Chemicals And Allied Products | 718 out of 1,854 | 61st |
Industry group Drugs | 571 out of 1,528 | 63rd |
Industry Pharmaceutical Preparations | 449 out of 1,182 | 62nd |
Source: SEC filing on April 12, 2016.
DeSouza's colleagues
We found two more compensation records of executives who worked with Warren L. DeSouza at Aimmune Therapeutics in 2015.